Stoneridge Investment Partners v. Scientific-Atlanta (2008): what Delaware LLC founders should know

Case at a glance

• Case name: Stoneridge Investment Partners v. Scientific-Atlanta
• Year: 2008
• Court: US Supreme Court
• Citation: 552 U.S. 148 (2008)
• Category: Member Disputes

The facts

Securities-fraud class action against secondary actors.

The holding

Limited Section 10(b) liability for secondary actors.

Why this case matters

Federal securities-law case.

What this means for Delaware LLC founders

Rarely directly applicable.

How Stoneridge applies to your LLC

For solo single-member Delaware LLC founders, most fiduciary-duty cases have limited direct application: there is no co-member to owe duties to, and creditor-fiduciary-duty exposure arises only after actual insolvency. The cases become more relevant as the LLC grows:

• Adding co-founders or investors: multi-member LLCs face the full range of fiduciary-duty analysis, though Operating Agreements can modify duties under § 18-1101.
• Manager-managed structures: when non-member managers run the LLC, they owe fiduciary duties to members by default (§ 18-1104).
• Sale or merger transactions: Revlon and Unocal duties translate to LLC change-of-control transactions.
• Member disputes: Court of Chancery jurisdiction over Operating Agreement disputes applies the body of Delaware case law as guidance.

Primary source

The full text of Stoneridge Investment Partners v. Scientific-Atlanta is available through Westlaw, LexisNexis, and Google Scholar. The Delaware Court of Chancery publishes opinions at courts.delaware.gov/chancery. The Delaware Supreme Court publishes opinions at courts.delaware.gov/supreme.

Related cases and concepts

For broader Delaware corporate and LLC case law context, see our coverage of the business judgment rule, fiduciary duties, Delaware Court of Chancery, and the Delaware LLC Act. The Delaware Limited Liability Company Act sections (6 Del. C. § 18-101 et seq.) interact with the body of Delaware case law to define LLC governance.

See all cases in the Delaware Case Law Library →

What dispute actually reached the US Supreme Court in Stoneridge?

Stoneridge Investment Partners v. Scientific-Atlanta was a securities-fraud class action brought against secondary actors rather than against the company whose financial statements were said to be misleading. The plaintiffs were investors who held shares and argued that certain business partners of the issuer had taken part in arrangements that, in their view, helped the issuer present a healthier financial picture than the underlying reality supported. Crucially, the defendants in this slice of the case were not the issuer itself. They were outside parties whose ordinary commercial dealings allegedly fed into the numbers that investors later relied on. The record before the US Supreme Court framed this as a question about the reach of federal securities law, specifically how far private liability extends beyond the company that actually spoke to the market.

The reason this distinction matters is that federal securities law gives investors a private right to sue for certain kinds of fraud, but that right has limits. The investors here wanted to hold parties responsible even though those parties had not themselves made any public statement to the investing market. The case therefore turned on a narrow but consequential issue: when a third party engages in transactions with a company, and those transactions are later reflected in the company's disclosures, can investors sue that third party directly under the federal anti-fraud rule. The Court took the case to resolve how the private remedy applies to actors who sit one step removed from the statements investors read. As decided in 2008 and reported at 552 U.S. 148, the answer shaped the boundaries of that private remedy.

Who were the parties, and why does "secondary actor" matter?

A "primary actor" in securities-fraud terms is generally the party that makes the misleading statement or directly engages in the deceptive conduct that reaches investors. A "secondary actor" is a party further from that statement, such as a supplier, customer, advisor, or counterparty whose conduct may have contributed to the situation but who did not personally communicate with the market. Stoneridge was about secondary actors. The investors argued that these outside parties were close enough to the alleged scheme that they should answer for the resulting losses, even though the public-facing disclosures came from the issuer. The defendants countered that they had simply done business with the company and that investors had never seen, relied on, or even known about their conduct.

This framing is useful even for readers who never expect to litigate a securities case, because it captures a recurring legal theme: liability tends to track responsibility for the specific harm, not mere proximity to it. Courts repeatedly distinguish between the party that caused the relied-upon harm and parties who were nearby in the chain of commerce. The labels below help keep the roles straight when reading about this case:

• Issuer: the company whose financial statements reached investors. It was not the defendant in this part of the dispute.
• Secondary actors: outside parties whose ordinary business dealings were said to feed into the issuer's numbers.
• Investors: the class plaintiffs who bought shares and later claimed losses tied to allegedly misleading disclosures.
• The market link: the question of whether investors actually relied on anything the secondary actors said or did.

What was the precise legal question the Court answered?

The legal question was about the scope of private liability for secondary actors under the federal securities anti-fraud provision, often discussed as Section 10(b) and its associated rule. The investors wanted the private right of action to reach parties who participated in underlying transactions but who never made a public misstatement. The Court had to decide whether that private remedy stretched that far, or whether it stopped at parties on whose statements or conduct investors actually relied. Put plainly, the issue was whether being involved in a transaction that later showed up in someone else's disclosures is enough to expose a party to an investor lawsuit under the federal rule.

This is a question about the edges of a remedy, not about whether fraud is wrong. Everyone agrees fraud is actionable. The hard part is defining who may be sued privately and on what theory. The record reflects a tension that runs through securities law: investors want broad protection, while courts worry that an open-ended remedy could sweep in routine commercial counterparties who never spoke to the market. The Court in 2008 resolved that tension in a specific way for secondary actors. Reading the question carefully is the key to understanding the holding, because the holding is a direct response to this framing rather than a broad pronouncement about corporate honesty in general.

What did the Court actually hold in 2008?

Consistent with the record, the Court limited Section 10(b) liability for secondary actors. In practical terms, the decision narrowed the ability of private investors to sue outside parties who had engaged in transactions with an issuer but who had not themselves made the statements that investors relied on. The holding reflected the view that the private remedy depends on a real connection between the defendant's conduct and the investor's reliance. Where that connection is missing, because the defendant never communicated with the market and investors never relied on the defendant's conduct, the private action does not reach the secondary actor. This is why the case is cited as a boundary-setting decision on who can be pursued under the federal anti-fraud provision.

It is worth stating clearly what the decision did not do. It did not hold that the underlying conduct was acceptable, and it did not strip regulators of their separate enforcement powers. The ruling addressed the private investor remedy and where it ends for parties one step removed from the market-facing statement. For readers approaching this as general legal information, the takeaway is structural: federal securities law channels private claims toward parties whose statements or conduct investors genuinely relied upon, and it resists extending that private claim to every counterparty in a commercial chain. That is the doctrine the case applied and reinforced, and it is the reason the decision is grouped with disputes about the limits of liability rather than with cases that expand it.

Why is a federal securities case listed alongside Delaware case law?

Stoneridge is a US Supreme Court decision about federal securities law, not a Delaware state-law ruling about corporate or limited liability company governance. The record itself notes that it is a federal securities-law case and that it is rarely directly applicable to most founders. We include it here because founders researching Delaware entities often encounter securities concepts when they raise money, issue interests, or bring in investors, and it helps to see where a famous federal case fits and where it does not. Being honest about that boundary is part of giving useful information. The case does not interpret the Delaware General Corporation Law or the Delaware Limited Liability Company Act, and it does not set a Delaware fiduciary standard.

That said, the decision carries a transferable idea that does touch how founders think about responsibility and disclosure. The case stands for the principle that liability under a private remedy attaches to parties who actually made or were responsible for the relied-upon representation, not to every party in the surrounding commercial web. A founder who understands this distinction is better positioned to see why the identity of the speaker, and the question of who relied on what, matters so much in disputes. So while the holding does not govern Delaware LLC internal affairs, the analytical habit it models, asking who said what and who relied on it, is genuinely useful when reading any governance or investor document.

How does the "who made the statement" idea map onto an LLC operating agreement?

A Delaware LLC is governed primarily by its operating agreement and by the Delaware Limited Liability Company Act, not by federal securities precedent. Even so, the Stoneridge habit of asking precisely who made a representation, and to whom, translates well into how an operating agreement is read. Operating agreements routinely allocate who has authority to speak for the company, who may bind it, and what representations members or managers make to one another. When a dispute arises, the analysis often starts with identifying the specific statement, the party responsible for it, and the party who relied on it. That is the same chain of questions the securities context uses, even though the governing law is entirely different.

For an LLC, the practical point is that clarity about authority and representations reduces ambiguity later. Founders can use the operating agreement to make these lines explicit rather than leaving them to inference:

• Which members or managers are authorized to make binding statements on behalf of the company.
• What representations and warranties members give when they join or contribute capital.
• How information is shared with members, and what records they may inspect.
• What happens when a member relies on information that turns out to be inaccurate.

None of this is a securities-law requirement under Stoneridge. It is simply that the same discipline about identifying speakers and reliance tends to produce cleaner governance and fewer disputes inside a Delaware LLC.

Does this case change fiduciary duties inside a Delaware LLC?

It does not. Fiduciary duties inside a Delaware LLC are shaped by the Delaware Limited Liability Company Act and by the operating agreement, and Delaware is well known for allowing significant contractual freedom in this area. The Act permits members to expand, restrict, or in many respects modify default duties through the operating agreement, subject to limits such as the covenant of good faith and fair dealing. Stoneridge, by contrast, is a federal securities decision about who may be sued by investors for fraud connected to public market statements. The two operate in separate legal lanes, and a reader should not treat the securities holding as a statement about manager or member loyalty and care under Delaware law.

The reason it is worth naming the difference is that founders sometimes assume one famous case controls everything about corporate responsibility. In reality, an LLC's internal duties come from its chosen agreement and the Act, while investor-facing fraud liability comes from a different body of law. The common thread is responsibility for representations, but the doctrines, standards, and remedies are distinct. Where an operating agreement modifies fiduciary duties, members should understand what protections they are keeping and what they are giving up, because the contractual freedom Delaware allows can shift the balance considerably. Stoneridge does not alter that analysis in either direction.

What should a non-resident founder take from this case in practical terms?

For a non-resident founder forming a Delaware LLC, the direct relevance of Stoneridge is limited, and it is fair to say so. The record describes it as rarely directly applicable, and that is an accurate guide. A founder building a small or early-stage company is unlikely to be in the position of the secondary actors in that case. The more useful takeaway is conceptual: representations matter, and the question of who made a statement and who relied on it can be decisive when something goes wrong. That lesson informs how a founder approaches investor communications, capital raises, and the documents that accompany them, even though the LLC's internal governance is a separate matter under Delaware law.

In practical terms, a careful founder treats accuracy in disclosures as a habit rather than an afterthought. The following points reflect general legal information rather than advice for a specific situation:

• Be precise about who is authorized to speak for the company and in what capacity.
• Keep representations to investors and members consistent with the underlying facts.
• Recognize that raising capital can bring federal and state securities considerations that are separate from LLC governance.
• Consider qualified counsel before issuing interests or making investor-facing statements, since securities questions are fact-specific.

How does Stoneridge relate to contractual freedom under the Delaware LLC Act?

Delaware's LLC framework is often described in terms of freedom of contract, meaning that the members can design much of their internal relationship through the operating agreement. The Delaware Limited Liability Company Act supplies default rules and a backstop of mandatory provisions, but it leaves a wide field for tailoring governance, economics, and duties. Stoneridge has nothing to say about this contractual freedom directly, because it concerns a federal remedy for investor fraud. Yet the contrast is instructive. Inside the LLC, the members can shape responsibility by agreement. In the securities context the case addresses, liability is defined by statute and case law and is not something the parties can simply contract around with respect to outside investors.

Understanding that contrast helps a founder avoid a common confusion. The freedom to allocate duties and risk within an operating agreement is real and powerful, and Delaware courts generally respect carefully drafted terms. That internal freedom does not extend to redefining external obligations owed to the investing public under federal law, which is the domain Stoneridge sits in. So a founder can use the operating agreement to manage relationships among members and managers, while treating investor-facing securities questions as a separate and more rigid area. Keeping these two spheres distinct is one of the more useful mental models a founder can carry, and reading Stoneridge in this light reinforces where each set of rules begins and ends.

What is the doctrinal legacy of limiting secondary-actor liability?

The doctrinal legacy of Stoneridge is a narrower path for private investor suits against parties who did not make the relied-upon statements. By limiting Section 10(b) liability for secondary actors, the decision reinforced that the private remedy is tied to reliance and to the party responsible for the market-facing representation. This had downstream effects on how plaintiffs frame claims, encouraging them to focus on parties whose own statements or conduct investors actually relied upon. The case is therefore often discussed as part of a line of decisions that define the perimeter of private securities litigation rather than as a ruling that expands it.

For the purposes of this site, the legacy worth remembering is the analytical one. The decision keeps a clear focus on the link between conduct and reliance, and on the identity of the party responsible for the relevant statement. That focus is a recurring feature of well-reasoned liability analysis across many areas of law, including how courts read governance and investor documents. A founder who internalizes the idea that responsibility follows the relied-upon representation will read agreements and disclosures with sharper questions. While the holding itself lives in federal securities law and is rarely directly applicable to a typical Delaware LLC, the underlying discipline travels well beyond the case's immediate facts.

How should this page be used, and what are its limits?

This page offers general legal information about a US Supreme Court decision reported at 552 U.S. 148 (2008). It is grounded in the case's recorded facts and holding: a securities-fraud class action against secondary actors, resolved by limiting Section 10(b) liability for those actors. It is not legal advice, and it does not analyze any particular company, transaction, or dispute. Securities questions are highly fact-specific, and the application of any principle depends on details that a short summary cannot capture. Readers facing an actual issue involving investor representations, capital raising, or potential fraud claims should consult qualified counsel who can evaluate the specific facts.

It is also worth repeating the honest framing from the underlying record: this federal securities case is rarely directly applicable to most founders forming a Delaware LLC. We include it because founders sometimes encounter the case when researching corporate accountability, and it helps to place it correctly. The internal governance of a Delaware LLC is shaped by the operating agreement and the Delaware Limited Liability Company Act, while investor-facing fraud liability sits in a separate body of federal and state securities law. Keeping those categories distinct, and understanding that responsibility tends to follow the party who made the relied-upon statement, is the most durable lesson a careful reader can take from this case.